Literature DB >> 9215653

Cross-sectional and longitudinal evaluation of body composition in men with HIV infection.

K Mulligan1, V W Tai, M Schambelan.   

Abstract

Body wasting is an increasingly prevalent AIDS-defining condition and an independent risk factor for mortality in patients infected with HIV. Largely on the basis of studies conducted early in the epidemic, HIV-associated wasting has been assumed to feature a disproportionate loss of lean tissue. We report the results obtained from cross-sectional and longitudinal studies that differ from these earlier observations. In a cross-sectional analysis, weight and body composition determined by dual-energy x-ray absorptiometry and bioelectrical impedance analysis in 32 HIV-infected men with documented weight loss of > or = 10% were compared to those in 46 HIV-positive men without significant weight loss and 32 HIV-negative controls. Fat, lean body mass (LBM), and body cell mass (BCM) were significantly lower in men with weight loss relative to controls (p < 0.001 for fat and BCM; p = 0.01 for LBM). Two thirds of the difference in weight was fat. For the longitudinal analysis, the composition of weight lost over time was evaluated in paired measurements in men grouped by body fat content (<15% or >15%, n = 10 per group). Weight loss in patients with baseline fat of more than 15% was only 16% LBM, but the composition of weight lost in men with baseline fat of less than 15% was 70% LBM. We conclude that progressive decreases in fat and lean tissue occur in men with HIV infection, with the composition of weight lost depending on baseline fat content. These results argue against the widely held notion that HIV-associated wasting is characterized by preservation of fat at the expense of lean tissue.

Entities:  

Mesh:

Year:  1997        PMID: 9215653     DOI: 10.1097/00042560-199705010-00007

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  14 in total

1.  Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors.

Authors:  Carl Grunfeld; Donald P Kotler; Donna K Arnett; Julian M Falutz; Steven M Haffner; Paul Hruz; Henry Masur; James B Meigs; Kathleen Mulligan; Peter Reiss; Katherine Samaras
Journal:  Circulation       Date:  2008-06-19       Impact factor: 29.690

Review 2.  Adipose Tissue in HIV Infection.

Authors:  John R Koethe
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

3.  Health & nutritional status of HIV infected children.

Authors:  Rakesh Lodha; S K Kabra
Journal:  Indian J Med Res       Date:  2015-01       Impact factor: 2.375

4.  Nutritional aspects of HIV-associated wasting in sub-Saharan Africa.

Authors:  John R Koethe; Douglas C Heimburger
Journal:  Am J Clin Nutr       Date:  2010-02-10       Impact factor: 7.045

5.  Heavy injection drug use is associated with lower percent body fat in a multi-ethnic cohort of HIV-positive and HIV-negative drug users from three U.S. cities.

Authors:  Alice M Tang; Janet E Forrester; Donna Spiegelman; Timothy Flanigan; Adrian Dobs; Sally Skinner; Christine Wanke
Journal:  Am J Drug Alcohol Abuse       Date:  2010-01       Impact factor: 3.829

6.  Fibroblast growth factor 21 decreases after liver fat reduction via growth hormone augmentation.

Authors:  Laurie R Braun; Meghan N Feldpausch; Natalia Czerwonka; Martin Torriani; Steven K Grinspoon; Takara L Stanley
Journal:  Growth Horm IGF Res       Date:  2017-10-07       Impact factor: 2.372

7.  Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals.

Authors:  Kevin E Yarasheski; Rebecca Scherzer; Donald P Kotler; Adrian S Dobs; Phyllis C Tien; Cora E Lewis; Richard A Kronmal; Steven B Heymsfield; Peter Bacchetti; Carl Grunfeld
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-02-10       Impact factor: 6.053

8.  Malnutrition in a population of HIV-positive and HIV-negative drug users living in Chennai, South India.

Authors:  Alice M Tang; Tarun Bhatnagar; Ramakrishnan Ramachandran; Kimberly Dong; Sally Skinner; M Suresh Kumar; Christine A Wanke
Journal:  Drug Alcohol Depend       Date:  2011-03-21       Impact factor: 4.492

Review 9.  The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications.

Authors:  Oliver P Flint; Mustafa A Noor; Paul W Hruz; Phil B Hylemon; Kevin Yarasheski; Donald P Kotler; Rex A Parker; Aouatef Bellamine
Journal:  Toxicol Pathol       Date:  2009-01-26       Impact factor: 1.902

10.  Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting.

Authors:  N F Gonzalez-Cadavid; W E Taylor; K Yarasheski; I Sinha-Hikim; K Ma; S Ezzat; R Shen; R Lalani; S Asa; M Mamita; G Nair; S Arver; S Bhasin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.